An industry-supported symposium at ICNMD 2024
This symposium is organised and sponsored by PTC Therapeutics International Limited and is intended for healthcare professionals only.
Sunday 27 October 2024 | 1:00–2:00 pm AWST
Information on PTC products will be discussed during this symposium that are not approved by the TGA for use in Australia.
Address
River View Room 4,
Perth Convention and Exhibition Centre,
Perth, WA, Australia
Find out more about our expert faculty and the objectives of this symposium.
Click here to downloadThis symposium is organised and sponsored by PTC Therapeutics International Limited and is intended for healthcare professionals only. This presentation was approved by the Scientific Program Committee as an independent activity held in conjunction with the 18th International Congress on Neuromuscular Diseases. This presentation is not sponsored or endorsed by ICNMD 2024.
https://www.ptcbio.com/privacy-statement/
https://www.ptcbio.ie/privacy-statement
https://www.ptcbio.com/terms-of-use/
Oxford PharmaGenesis privacy statement
nmDMD, nonsense mutation Duchenne muscular dystrophy; TGA, Therapeutic Goods Administration.
© 2024 PTC Therapeutics International Limited. All rights reserved. Trademarks, registered or otherwise, are the property of their respective owners. PTC Therapeutics International Limited, Unit 1, 52–55 Sir John Rogerson’s Quay, Dublin 2, D02 NA07, Ireland.
MED-ALL-ATLN-2400015 | Date of preparation: September 2024